| Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016 I Galani, I Karaiskos, I Karantani, V Papoutsaki, S Maraki, V Papaioannou, ... Eurosurveillance 23 (31), 1700775, 2018 | 89 | 2018 |
| Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies I Karaiskos, I Galani, V Papoutsaki, L Galani, H Giamarellou Expert Review of Anti-Infective Therapy 20 (1), 53-69, 2022 | 41 | 2022 |
| Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment I Galani, I Karaiskos, E Angelidis, V Papoutsaki, L Galani, M Souli, ... European Journal of Clinical Microbiology & Infectious Diseases 40 (1), 219-224, 2021 | 40 | 2021 |
| Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece … I Galani, I Karaiskos, M Souli, V Papoutsaki, L Galani, A Gkoufa, ... Eurosurveillance 25 (3), 2000028, 2020 | 40 | 2020 |
| In vitro activity of ceftolozane/tazobactam alone and in combination with amikacin against MDR/XDR Pseudomonas aeruginosa isolates from Greece I Galani, V Papoutsaki, I Karantani, I Karaiskos, L Galani, P Adamou, ... Journal of Antimicrobial Chemotherapy 75 (8), 2164-2172, 2020 | 26 | 2020 |
| In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream … I Galani, V Papoutsaki, I Karaiskos, N Moustakas, L Galani, S Maraki, ... European Journal of Clinical Microbiology & Infectious Diseases 42 (7), 843-852, 2023 | 12 | 2023 |
| Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing Klebsiella pneumoniae isolates V Papoutsaki, I Galani, E Papadimitriou, I Karantani, I Karaiskos, ... Journal of Global Antimicrobial Resistance 20, 98-104, 2020 | 4 | 2020 |
